340B Insight provides members and supporters of 340B Health with timely updates and discussions about the 340B drug pricing program. The podcast helps listeners stay current with and learn more about 340B to help them serve their patients and communities and remain compliant. We publish new episodes twice a month, with news reports and in-depth interviews with leading health care practitioners, policy and legal experts, public policymakers, and our expert staff.

340B Insight
Claim This Podcastby 340B Health
Podcast Authority
Beta
Podcast Overview
340B Insight provides members and supporters of 340B Health with timely updates and discussions about the 340B drug pricing program. The podcast helps listeners stay current with and learn more about 340B to help them serve their patients and communities and remain compliant. We publish new episodes twice a month, with news reports and in-depth interviews with leading health care practitioners, policy and legal experts, public policymakers, and our expert staff.
Language
🇺🇲
Publishing Since
5/4/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
3 verified contact emails on file for 340B Insight
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

July 27, 2026
Why Your Hospital Might Consider Opening a Retail Pharmacy
Sherstin Willyerd, director of pharmacy operations at Montgomery County Memorial Hospital, shares how her hospital opened a retail pharmacy to navigate 340B restrictions and better serve patients, in this interview.

July 13, 2026
What Illinois 340B Advocates Did To Succeed on 340B Protections
Thomas Yu, system director of ambulatory pharmacy services at Sinai Chicago, shares how Illinois 340B advocates achieved legislative protections for contract pharmacy access and data demands, offering lessons for other states.

June 29, 2026
How Courts Are Shaping the Future of 340B
Amanda Nagrotsky, Vice President of Legal and Policy at 340B Health, explains how ongoing court cases are shaping the future of the 340B drug pricing program.
141 total episodes available with 4 transcripts
Recent guests on 340B Insight
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Sherstin Willyerd
Guest
Thomas Yu
Guest
Amanda Nagrotsky
Guest
Steven Miller
Guest
Angela Campitelli
Guest
Adam Porath
Guest
Similar Podcasts
Discover related shows you might enjoy

340B Unscripted
SpendMend Pharmacy

Inside 340B Report
340B Report

340B 360
340B Report

340B Pulse
NorthArcHealth

KFF Health News' 'What the Health?'
KFF Health News

The Clark Howard Podcast
Clark Howard

Up First
NPR

The Daily
The New York Times

The Daily Punch
Punchbowl News

Morning Brew Daily
Morning Brew

The NPR Politics Podcast
NPR

WSJ What’s News
The Wall Street Journal

POLITICO Playbook Daily Briefing
POLITICO

The Journal.
The Wall Street Journal & Spotify Studios

The Headlines
The New York Times
Deep-dive analytics for 340B Insight
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is 340B Insight?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.